The complaints state they were removed from leadership as a reaction to their objections to hostility toward vaccines, politicization, and suspension of funding for clinical trials and foreign research.
Tariff proposals highlight the reliance on offshore drug production, the challenges of reshoring generics, and the need for investment to stabilize supply chains.
Bringing together hospital and healthcare leaders for the last 17 years. If you are a healthcare leader looking to network with other healthcare & hospital leaders, we hope to see you on the road in 2025!
